Stone Ridge Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,099
Closed -$1.47M 1016
2019
Q3
$1.47M Hold
13,099
0.09% 277
2019
Q2
$1.45M Hold
13,099
0.09% 281
2019
Q1
$1.7M Sell
13,099
-2,061
-14% -$251K 0.1% 251
2018
Q4
$1.75M Hold
15,160
0.11% 204
2018
Q3
$1.63M Hold
15,160
0.09% 263
2018
Q2
$1.29M Hold
15,160
0.07% 312
2018
Q1
$1.17M Sell
15,160
-11,200
-42% -$902K 0.07% 328
2017
Q4
$2.23M Buy
+26,360
New +$2.24M 0.14% 150
2015
Q3
Sell
-4,200
Closed -$350K 109
2015
Q2
$350K Buy
+4,200
New +$320K 0.81% 28

Other funds holding LLY

Stone Ridge Asset Management's LLY Position: Q4 2019 in Review

Stone Ridge Asset Management sold out of Eli Lilly (LLY) in Q4 2019, closing a stake of 13,099 shares — an estimated $1.47M sold.

Stone Ridge Asset Management first reported a position in LLY in Q2 2015 and held it in 9 quarters. The position peaked at $2.23M in Q4 2017. 1,672 funds tracked by Wall St. Rank hold LLY as of Q4 2019.

  • Stone Ridge Asset Management reported no remaining Eli Lilly position as of Q4 2019 after selling out during the quarter.
  • Stone Ridge Asset Management sold 13,099 Eli Lilly shares in Q4 2019, an estimated $1.47M.
  • Stone Ridge Asset Management first reported a position in Eli Lilly in Q2 2015 and held it in 9 quarters.
  • Stone Ridge Asset Management's Eli Lilly position peaked at $2.23M in Q4 2017.
  • 1,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2019.

Based on Stone Ridge Asset Management's 13F filing for Q4 2019, filed 6 Feb 2020.